Concordance Between Peri-Areolar Blue Dye and Peri-Incisional Radiotracer Injections for Sentinel Node Mapping in Patients with a History of Primary Breast Cancer Excisonal Biopsy

References

• Schulze T., Bembenek A., Schlag P. M. Sentinel lymph node biopsy progress in surgical treatment of cancer. Langenbecks Arch Surg, 2004, 389: 532–550.
   Google Scholar
• Ruano Perez R., Ramos Boyero M., Garcia-Talavera Fernandez J. R. et al. Incidence of axillary recurrence after a negative sentinel lymph node result in early stages of breast cancer: a 5-year follow-up. Rev Esp Med Nucl, 2012, 31: 173–177.
   Google Scholar
• Noguchi A., onoguchi M., ohnishi T. et al. Predicting sentinel lymph node metastasis in breast cancer with lymphoscintigraphy. Ann Nucl Med, 2011, 25: 221–226.
   Google Scholar
• van Eetvelde E., vanhoeij M., verfaillie G., Bourgain c., Lamote J. Role of intra-operative touch imprint cytology in the treatment of breast cancer. Acta Chir Belg, 2011, 111: 130–135.
   Google Scholar
• Jangjoo A., Forghani M. N., Mehrabibahar M. et al. Comparison of early and delayed lymphoscintigraphy images of early breast cancer patients undergoing sentinel node mapping. Nucl Med Com-mun, 2010, 31: 521–525.
   Google Scholar
• Goyal A., Newcombe R. G., chhabra A., Mansel R. E. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer — results of the ALMANAC validation phase. Breast Cancer Res Treat, 2006, 99: 203–208.
   Google Scholar
• Aliakbarian M., Memar B., Jangjoo A. et al. Factors influencing the time of sentinel node visualization in breast cancer patients using intradermal injection of the radiotracer. Am J Surg, 2011, 202: 199–202.
   Google Scholar
• Abdollahi A., Jangjoo A., Dabbagh Kakhki V. R. et al. Factors affecting sentinel lymph node detection failure in breast cancer patients using intradermal injection of the tracer. Rev Esp Med Nucl, 2010, 29: 73–77.
   Google Scholar
• Forghani M. N., Memar B., Jangjoo A. et al. The effect of exci-sional biopsy on the accuracy of sentinel lymph node mapping in early stage breast cancer: Comparison with core needle biopsy. Am Surg, 2010, 76: 1232–1235.
   Google Scholar
• Feldman S. M., Krag D. N., McNally R. K., Moor B. B., weaver D. L., Klein P. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J Am Coll Surg, 1999, 188: 248–254.
   Google Scholar
• Estourgie S. H., Valdes Olmos R. A., Nieweg O. E., Hoefnagel c. A., Rutgers E. J., Kroon B. B. Excision biopsy of breast lesions changes the pattern of lymphatic drainage. Br J Surg, 2007, 94: 1088–1091.
   Google Scholar
• Somasundaram S. K., chicken D. W., Waddington W. A., Bomanji J., Ell P. J., Keshtgar M. R. Sentinel node imaging in breast cancer using superficial injections: technical details and observations. Eur J Surg Oncol, 2009, 35: 1250–1256.
   Google Scholar
• Marrazzo A., Taormina P., Gebbiab V. et al. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients ? Chir Ital, 2007, 59: 693–699.
   Google Scholar
• Borgstein P. J., Pijpers R., comans E. F., van Diest P. J., Boom R. P., Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg, 1998, 186: 275–283.
   Google Scholar
• Bergkvist L. Resolving the controversies surrounding lymphatic mapping in breast cancer. Future Oncol, 2008, 4: 681–688.
   Google Scholar
• Asoglu O., Ozmen V., Karanlik H. et al. The role of sentinel lymph node biopsy with blue dye alone in breast cancer patients with excisional biopsy. Acta Chir Belg, 2005, 105: 291–296.
   Google Scholar
• Javan H., Gholami H., Assadi M., Pakdel A. F., Sadeghi R., Keshtgar M. The accuracy of sentinel node biopsy in breast cancer patients with the history of previous surgical biopsy of the primary lesion: systematic review and meta-analysis of the literature. Eur J Surg Oncol, 2012, 38: 95–109.
   Google Scholar
• Giuliano A. E., Kirgan D. M., Guenther J. M., Morton D. L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg, 1994, 220: 391–398.
   Google Scholar
• Borgstein P. J., Meijer S., Pijpers R. J., van Diest P. J. Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method. Ann Surg, 2000, 232: 81–89.
   Google Scholar
• Borgstein P. J., Meijer S., Pijpers R. Intradermal blue dye to identify sentinel lymph-node in breast cancer. Lancet, 1997, 349: 1668–1669.
   Google Scholar
• zavagno G., Rubello D., Franchini Z. et al. Axillary sentinel lymph nodes in breast cancer: a single lymphatic pathway drains the entire mammary gland. Eur J Surg Oncol, 2005, 31: 479–484.
   Google Scholar
• Dixon J. M., Mak c., Radhakrishna S. et al. Effectiveness of immediate preoperative injection of radiopharmaceutical and blue dye for sentinel node biopsy in patients with breast cancer. Eur J Cancer, 2009, 45: 795–799.
   Google Scholar
• Fetzer S., Holmes S. Relieving the pain of sentinel lymph node biopsy tracer injection. Clin J Oncol Nurs, 2008, 12: 668–670.
   Google Scholar
• Nunez M., Alonso O., Mut F., Vila R., Beretta M., Illutton B. F. Detectability of sentinel nodes in lymphoscintigraphy as a function of collimator type and distance from the injection site: A phantom study. J Nucl Med Technol, 2004, 32: 105–106.
   Google Scholar